Company intelligence / Profile preview

Anthrogenesis

Warren, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Anthrogenesis, operating as Celgene Cellular Therapeutics, is a biotechnology company focused on the development of placental-derived stem cell therapies. The company specializes in harvesting and processing stem cells from the human placenta to treat a variety of inflammatory, autoimmune, and degenerative diseases. Its research focuses on the immunomodulatory and regenerative properties of these cells, aiming to provide off-the-shelf cellular products. Anthrogenesis was a pioneer in the field of placental stem cell banking and therapeutic application before being integrated into larger pharmaceutical structures.

Therapeutic areas: NeurologyImmunologyEndocrinologyGastroenterology
Modalities: Cell therapyStem cell therapy
Industry: Pharma

Partnerships

CelgeneBristol Myers Squibb

Beyond the preview

Go deeper on Anthrogenesis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anthrogenesis.

Explore the full profile